SCHEMBL17066524

SCHEMBL17066524

Cc1ccc(NC(=O)C(Sc2cccc[n+]2O)c2ccccc2)cc1Cl

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PCTP Q9UKL6 7/20 0.79
STARD10 Q9Y365 2/20 0.56
STARD7 Q9NQZ5 1/20 0.56
ALDH1A1 P00352 7/20 0.54
LMNA P02545 5/20 0.49
MAPT P10636 5/20 0.49
HTR1E P28566 3/20 0.49
S1PR3 Q99500 3/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
GAA P10253 1/20 0.49
HTT P42858 1/20 0.48
MEN1 O00255 4/20 0.47
KMT2A Q03164 4/20 0.47
SMN1; SMN2 Q16637 4/20 0.47
RECQL P46063 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
POLB P06746 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1235095 0.88 PCTP (1.00) PCTPSTARD10STARD7ALDH1A1LMNA
SCHEMBL17066522 0.86 PCTP (0.80) PCTPSTARD10STARD7ALDH1A1LMNA
SCHEMBL17066575 0.84 PCTP (0.77) PCTPSTARD10STARD7ALDH1A1LMNA
SCHEMBL12903628 0.81 PCTP (0.77) PCTPSTARD10STARD7ALDH1A1LMNA
SCHEMBL17066590 0.77 PCTP (0.79) PCTPSTARD10STARD7ALDH1A1LMNA
SCHEMBL17066525 0.77 PCTP (0.78) PCTPSTARD10STARD7ALDH1A1LMNA
SCHEMBL16358447 0.75 PCTP (0.51) PCTPSTARD10STARD7ALDH1A1LMNA
SCHEMBL17066491 0.75 SMN1; SMN2 (0.58) PCTPSTARD10STARD7ALDH1A1LMNA
SCHEMBL16358245 0.75 ALDH1A1 (0.80) PCTPSTARD10STARD7ALDH1A1LMNA
SCHEMBL1235185 0.75 PCTP (1.00) PCTPSTARD10STARD7ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9556129-B2 Phosphatidylcholine transfer protein inhibitors THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) 2017-01-31 US disclosed
US-20150336902-A1 Phosphatidylcholine Transfer Protein Inhibitors THE BRIGHAM AND WOMEN'S HOSPITAL, INC. 2015-11-26 US disclosed
US-9126938-B2 Phosphatidylcholine transfer protein inhibitors THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) 2015-09-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150336902-A1 Phosphatidylcholine Transfer Protein Inhibitors PCTP, LCAT, CETP PCTP 1/4885STARD10 1028/4885STARD7 117/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.